EMA urges “human-centric approach” to AI in drug discovery
Drug Discovery World
JULY 20, 2023
The EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. The reflection paper highlights that a human-centric approach should guide all development and deployment of AI and ML.
Let's personalize your content